Raniszewska, A.
Vroman, H. https://orcid.org/0000-0002-4392-935X
Dumoulin, D.
Cornelissen, R.
Aerts, J. G. J. V.
DomagaĆa-Kulawik, J.
Article History
Received: 25 November 2019
Accepted: 18 June 2020
First Online: 17 August 2020
Compliance with ethical standards
:
: AR, HV, and JDK declare no conflict of interest. DD reports personal fees from Speakers fee: Roche, Pfitzer, and BMS outside the submitted work. RC reports personal fees from Speakers fee: Roche, Boehringer, Pfitzer, and personal fees from MSD advisory board outside the submitted work. JA reports personal fees from consultancy BMS, MSD, Boehringer-Ingelheim, Roche, ELI-Lilly, Amphera, and Takeda outside the submitted work. JA has a patent allogenic lysate for immunotherapy licensed.
: This study was performed following the ethical principles of the Helsinki Declaration. All patients permitted the usage of specimens and clinical data for research and publication under the condition of anonymity. The study was approved by Ethics Committee of Medical University of Warsaw (KB/230/16).